市場調查報告書
商品編碼
1463736
2030 年亞太地區減重手術市場預測 - 區域分析 - 按類型和最終用戶(醫院和門診手術中心)Asia Pacific Bariatric Surgeries Market Forecast to 2030 - Regional Analysis - by Type and End User (Hospitals and Ambulatory Surgical Centers) |
2022年亞太減重手術市場價值為9.1353億美元,預計2030年將達到31.1501億美元;預計2022年至2030年CAGR為16.6%。
市場參與者的策略性舉措推動亞太減重手術市場
全球肥胖盛行率不斷上升,這增加了對減肥手術設備的需求。各種市場參與者也專注於產品發布或策略合作,以開發有助於減肥手術並提供積極成果的先進產品。近年來出現了各種新的發展,例如產品發布、合併和收購。其中一些如下: 2022年11月,波士頓科學公司以總價值約6.15億美元收購Apollo Endosurgery Inc.,相當於每股10美元的現金價格。 Apollo Endosurgery 產品組合包括腔內手術 (ELS) 過程中使用的設備,用於閉合和管理胃腸道缺陷和併發症,以及幫助肥胖患者減肥。 2021 年 9 月,奧林巴斯收購了名為 POWERSEAL 的新型先進雙極手術能量產品系列。 POWERSEAL 5 mm 彎曲下顎組織密封器和分隔器是一種雙作用設備,透過以符合人體工學和多功能設計的方式提供恆定的密封可靠性,從而提高手術效率,滿足先進雙極手術能量設備的最高醫療性能標準。 POWERSEAL 裝置可用於多種外科手術,包括一般外科、婦科、結直腸、減重、泌尿外科、胸部和血管外科手術。
因此,產品發布、開發和策略合作的激增可能會在未來為減重手術設備市場創造可觀的成長機會。
亞太地區減重手術市場概況
亞太減肥手術市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。減重手術市場的成長廣泛受到公司合作、肥胖盛行率增加以及對微創手術需求不斷成長的推動。由於中國肥胖人口不斷成長,減肥手術在中國獲得了巨大的關注。其他因素,例如糖尿病的增加、心血管疾病 (CVD) 病例的增加以及市場參與者的發展也主要促進了該國減肥手術設備的成長,使其成為亞太地區的重要市場。
2022年9月,根據《全球健康雜誌》報道,肥胖已成為全球嚴重的公共衛生問題。中國是世界上超重人數最多的國家。中國超過50%的成年人和約20%的兒童和青少年體重超重。近20年來,我國在肥胖干預方面採取了多項行動,肥胖率持續成長。因此,中國對減重手術的需求正在成長。
一些市場參與者正在採取有機策略來保持市場競爭力。例如,2021 年 9 月,Olympus推出了 POWERSEAL 5mm 彎曲下顎組織密封器和分割器。該設備透過符合人體工學的多功能設計提供一致的密封可靠性,從而提高手術效率,滿足先進雙極手術能量設備的最高臨床性能標準。
上述因素可能會持續推動中國減重手術設備市場的成長。
亞太地區減重手術市場收入及 2030 年預測(百萬美元)
亞太地區減重手術市場區隔
亞太地區減重手術市場按類型、最終用戶和國家進行細分。
根據類型,亞太地區減重手術市場分為可調式胃束帶(AGB)、袖狀胃切除術、胃繞道手術、十二指腸開關膽胰改道術(bpd-ds)等。 2022 年,袖狀胃切除術細分市場佔據最大佔有率。
就最終用戶而言,亞太地區減重手術市場分為醫院和門診手術中心。 2022 年,醫院細分市場將佔據更大佔有率。
依國家分類,亞太地區減重手術市場分為中國、日本、印度、韓國、澳洲和亞太地區其他地區。 2022年,中國在亞太減重手術市場佔據主導地位。
Conmed Corp、Integra LifeSciences Holdings Corp、Intuitive Surgical Inc、Medtronic Plc、Olympus Corp 和 Reshape Lifesciences Inc 是亞太減肥手術市場上的一些領先公司。
表中的內容
The Asia Pacific bariatric surgeries market was valued at US$ 913.53 million in 2022 and is expected to reach US$ 3,115.01 million by 2030; it is estimated to grow at a CAGR of 16.6% from 2022 to 2030.
Strategic Initiatives by Market Players Fuels the Asia Pacific Bariatric Surgeries Market
There has been a constant increase in the prevalence of obesity on a global level that has increased the demand for bariatric surgery devices. Various market players are also focused on product launches or strategic collaborations for the development of advanced products that help during bariatric surgeries and provide positive outcomes. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years. A few of them are mentioned below: In November 2022, Boston Scientific Corporation acquired Apollo Endosurgery Inc. with a total value of approximately US$ 615 million, which indicated a cash price of US$ 10 per share. The Apollo Endosurgery product portfolio includes devices used during endoluminal surgery (ELS) procedures to close and manage gastrointestinal defects and complications, along with aid in weight loss for patients with obesity. In September 2021, Olympus acquired the new advanced bipolar surgical energy product range known as POWERSEAL. The POWERSEAL 5 mm Curved Jaw Tissue Sealer and Divider is a double-action device that meets the highest standards of medical performance for advanced bipolar surgical energy devices by delivering constant sealing reliability in an ergonomic and multifunctional design that promotes procedural efficiency. The POWERSEAL devices can be employed in numerous surgical procedures, including general, gynaecological, colorectal, bariatric, urological, thoracic, and vascular surgical procedures.
Thus, a surge in product launches, development, and strategic collaborations is likely to create considerable growth opportunities for the bariatric surgery devices market in the future.
Asia Pacific Bariatric Surgeries Market Overview
The Asia Pacific bariatric surgeries market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the bariatric surgeries market is widely driven by company collaborations, increasing prevalence of obesity, and growing demand for minimally invasive surgeries. Due to the growing obese population in China, bariatric surgeries are gaining significant traction in the country. Other factors such as growing diabetes, rising cases of cardiovascular diseases (CVDs), and developments by the market players are also majorly contributing to the growth of bariatric surgery devices in the country, making it a significant market in Asia Pacific.
In September 2022, according to the Global Health Journal, obesity has become a severe public health issue worldwide. China has the world's largest number of overweight people. Over 50% of adults and about 20% of children and adolescents in China are overweight. Over the past 20 years, China has taken many actions in obesity intervention, and obesity rates have continued to grow. Thus, the demand for bariatric surgeries is growing in China.
Several market players are adopting organic strategies to stay competitive in the market. For instance, in September 2021, Olympus launched the POWERSEAL 5mm Curved Jaw Tissue Sealer and Divider. The devices fulfil the highest clinical performance standards for advanced bipolar surgical energy devices by delivering consistent sealing reliability in an ergonomic, multifunctional design that encourages procedural efficiency.
The factors mentioned above are likely to continue to boost the growth of the bariatric surgery devices market in China.
Asia Pacific Bariatric Surgeries Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Bariatric Surgeries Market Segmentation
The Asia Pacific bariatric surgeries market is segmented into type, end user, and country.
Based on type, the Asia Pacific bariatric surgeries market is categorized adjustable gastric bands (AGB), sleeve gastrectomy, gastric bypass, biliopancreatic diversion with duodenal switch (bpd- ds), and others. The sleeve gastrectomy market segment held the largest share in 2022.
In terms of end user, the Asia Pacific bariatric surgeries market is bifurcated into hospitals and ambulatory surgical centers. The hospitals segment held a larger share in 2022.
Based on country, the Asia Pacific bariatric surgeries market is segmented China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific bariatric surgeries market in 2022.
Conmed Corp, Integra LifeSciences Holdings Corp, Intuitive Surgical Inc, Medtronic Plc, Olympus Corp, and Reshape Lifesciences Inc are some of the leading companies operating in the Asia Pacific bariatric surgeries market.
Table of Content